AstraZeneca to launch Crestor, the first member of a vast and fast-growing category of statins. The team responsible for the launch of the product considering how best to bring to market Crestor. If AstraZeneca simply follow the example of Pfizer with extremely successful launch of Lipitor? Or if the company instead of starting Crestor as a niche product? "Hide
by Tim Calkins, Joshua Neiman Source: Kellogg School Management 12 pages. Publication Date: January 1, 2006. Prod. #: KEL245-PDF-ENG
Related Case Solutions & Analyses:
Breaking Up is Never Easy: Planning for Exit in a Strategic Alliance
Cruzsalud: Health Care for Low-Sectors
ghSMART 2006: Pioneering in Professional Services
Balancing Family and Business Needs at Merck KGaA
Socially Responsible Pricing: Lessons from the Pricing of AIDS Drugs in Developing Countries
Shanghai Bell–The Collaborative Product Commerce Systems (CPC)
Private Management and Public Schools (A)
Biblio Credit Union: Social Inequality and the Living Wage
Linear Regression: A High-Level Overview
X Fire Paintball & Airsoft: is Amazon a Friend or Foe? (B)
